Table 2 Study outcomes
Povidone-iodine (n = XXX) | Chlorhexidine (n = XXX) | Odds ratio (95% CI) | ARR (95% CI) | p value | |
|---|---|---|---|---|---|
Primary outcome | |||||
Surgical site infection | |||||
Superficial infection by 30 days | – | ||||
Deep incisional by 90 days | – | ||||
Organ/space infection by 90 days | – | ||||
Alternative definitions of SSI | |||||
Any surgical site infection by 365 days | |||||
Fracture-related infection by 365 days | |||||
Secondary outcome | |||||
Unplanned reoperation by 365 days | |||||
Unplanned reoperation for infection by 365 days | – | ||||
Unplanned reoperation for wound healing complications by 365 days | – | ||||
Unplanned reoperation to promote fracture healing by 365 days | – | ||||